CSIMarket
 
Medtronic Plc  (NYSE: MDT)
Other Ticker:  
 
 

Medtronic Plc's Suppliers Performance

MDT's Supply Chain



 
 
MDT Costs vs Sales of Suppliers Growth Medtronic Plc's Suppliers recorded an increase in sales by 2.09 % year on year in Q4 2024, from the previous quarter, sales fell by -3.17 %, Medtronic Plc's cost of sales deteriorated by -0.11 % year on year, relative to one quarter ago cost of sales fell by -5.67 % in Q4.

More on MDT Suppliers




Medtronic Plc's Suppliers recorded an increase in sales by 2.09 % year on year in Q4 2024, from the previous quarter, sales fell by -3.17 %, Medtronic Plc's cost of sales deteriorated by -0.11 % year on year, compare to one quarter ago cost of sales fell by -5.67 % in Q4.

More on MDT Suppliers




Medtronic Plc's Comment on Supply Chain


We manufacture most of our products at 41 manufacturing facilities located in various countries throughout the world. The largest of these manufacturing facilities are located in Arizona, California, Colorado, Connecticut, Florida, Indiana, Massachusetts, Michigan, Minnesota, New Jersey, Texas, Puerto Rico, Canada, France, Germany, Ireland, Italy, Mexico, The Netherlands, The Peoples Republic of China, Singapore, and Switzerland. We purchase many of the components and raw materials used in manufacturing these products from numerous suppliers in various countries. For reasons of quality assurance, sole source availability, or cost effectiveness, certain components and raw materials are available only from a sole supplier. We work closely with our suppliers to help ensure continuity of supply while maintaining high quality and reliability. Due to the U.S. FDA’s requirements regarding manufacturing of our products, we may not be able to quickly establish additional or replacement sources for certain components or materials. Generally, we have been able to obtain adequate supplies of such raw materials and components. However, a sudden or unexpected reduction or interruption in supply, and an inability to develop alternative sources for such supply, could adversely affect our operations. Moreover, as directed by the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank), the SEC has implemented reporting and disclosure requirements related to the use of certain minerals, known as "conflict minerals": tantalum, tin, tungsten (or their ores), and gold; which are mined from the Democratic Republic of the Congo and adjoining countries. Pursuant to these requirements, we are required to report on Form SD the procedures we employ to determine the sourcing of such minerals and metals produced from those minerals. There are costs associated with complying with these disclosure requirements, including for diligence in regards to the sources of any conflict minerals used in our products, in addition to the cost of remediation and other changes to products, processes, or sources of supply as a consequence of such verification activities. In addition, the implementation of these rules could adversely affect the sourcing, supply, and pricing of materials used in our products. As of the date of our conflict minerals report for the 2013 calendar year, we were unable to obtain the necessary information on conflict minerals from all of our suppliers and were unable to determine that all of our products are conflict free. We may continue to face difficulties in gathering this information in the future. We may face reputational challenges if we determine that certain of our products contain minerals not determined to be conflict free or if we are unable to sufficiently verify the origins for all conflict minerals used in our products through the procedures we implement.

Medtronic Plc's Comment on Supply Chain


We manufacture most of our products at 41 manufacturing facilities located in various countries throughout the world. The largest of these manufacturing facilities are located in Arizona, California, Colorado, Connecticut, Florida, Indiana, Massachusetts, Michigan, Minnesota, New Jersey, Texas, Puerto Rico, Canada, France, Germany, Ireland, Italy, Mexico, The Netherlands, The Peoples Republic of China, Singapore, and Switzerland. We purchase many of the components and raw materials used in manufacturing these products from numerous suppliers in various countries. For reasons of quality assurance, sole source availability, or cost effectiveness, certain components and raw materials are available only from a sole supplier. We work closely with our suppliers to help ensure continuity of supply while maintaining high quality and reliability. Due to the U.S. FDA’s requirements regarding manufacturing of our products, we may not be able to quickly establish additional or replacement sources for certain components or materials. Generally, we have been able to obtain adequate supplies of such raw materials and components. However, a sudden or unexpected reduction or interruption in supply, and an inability to develop alternative sources for such supply, could adversely affect our operations. Moreover, as directed by the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank), the SEC has implemented reporting and disclosure requirements related to the use of certain minerals, known as "conflict minerals": tantalum, tin, tungsten (or their ores), and gold; which are mined from the Democratic Republic of the Congo and adjoining countries. Pursuant to these requirements, we are required to report on Form SD the procedures we employ to determine the sourcing of such minerals and metals produced from those minerals. There are costs associated with complying with these disclosure requirements, including for diligence in regards to the sources of any conflict minerals used in our products, in addition to the cost of remediation and other changes to products, processes, or sources of supply as a consequence of such verification activities. In addition, the implementation of these rules could adversely affect the sourcing, supply, and pricing of materials used in our products. As of the date of our conflict minerals report for the 2013 calendar year, we were unable to obtain the necessary information on conflict minerals from all of our suppliers and were unable to determine that all of our products are conflict free. We may continue to face difficulties in gathering this information in the future. We may face reputational challenges if we determine that certain of our products contain minerals not determined to be conflict free or if we are unable to sufficiently verify the origins for all conflict minerals used in our products through the procedures we implement.


MDT's Suppliers Net Income grew by MDT's Suppliers Net margin grew in Q4 to
4.39 % 7.37 %
MDT's Suppliers Net Income grew by 4.39 %


MDT's Suppliers Net margin grew in Q4 to 7.37 %


Medtronic Plc's Suppliers Sales Growth in Q4 2024 by Industry

Suppliers from Chemical Manufacturing Industry -19.55 %   
Suppliers from Chemicals - Plastics & Rubber Industry      1.11 %
Suppliers from Aluminum Industry      34.34 %
Suppliers from Iron & Steel Industry      0.27 %
Suppliers from Metal Mining Industry -25.24 %   
Suppliers from Miscellaneous Fabricated Products Industry      26.1 %
Suppliers from Industrial Machinery and Components Industry -1.28 %   
Suppliers from Conglomerates Industry -5.52 %   
Suppliers from Personal & Household Products Industry -1.17 %   
Suppliers from Oil & Gas Integrated Operations Industry      3.86 %
Suppliers from Medical Equipment & Supplies Industry -25 %   
Suppliers from Computer Peripherals & Office Equipment Industry -12.14 %   
Suppliers from IT Infrastructure Industry      3.79 %
Suppliers from Semiconductors Industry -9.17 %   
Suppliers from Software & Programming Industry      53.84 %
     





MDT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Medtronic Plc 113,532.87 33,199.00 4,290.00 100,000
3m Company 79,641.06 24,513.00 4,377.00 85,000
A negative correlation coefficient of -0.369 implies that the revenue of 3m Company does not correlate significantly with that of Medtronic Plc.
Alcoa Corp 7,571.40 12,665.00 879.00 13,600
The factor of 0.426 indicates a mild correlation between Alcoa Corp's revenue and those of Medtronic Plc.
Ati Inc 12,194.49 4,464.10 414.80 7,300
Ati Inc 's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.523
Chevron Corp 252,864.29 201,686.00 15,710.00 29,138
A negative correlation coefficient of -0.217 implies that the revenue of Chevron Corp does not correlate significantly with that of Medtronic Plc.
Dow Inc 21,687.69 42,630.00 373.00 35,900
The factor of 0.274 indicates a mild correlation between Dow Inc 's revenue and those of Medtronic Plc.
Eastman Chemical Co 9,167.24 9,362.00 926.00 14,500
The revenue of Eastman Chemical Co does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.057
Exxon Mobil Corporation 480,360.82 349,632.00 34,530.00 62,000
A negative correlation coefficient of -0.204 implies that the revenue of Exxon Mobil Corporation does not correlate significantly with that of Medtronic Plc.
Illinois Tool Works Inc 72,433.89 15,764.00 3,369.00 45,000
The revenue of Illinois Tool Works Inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.041
Worthington Enterprises Inc 3,036.85 2,858.74 195.22 9,220
A negative correlation coefficient of -0.164 implies that the revenue of Worthington Enterprises Inc does not correlate significantly with that of Medtronic Plc.
Nlight Inc 884.66 204.33 -55.12 1,271
A negative correlation coefficient of -0.084 implies that the revenue of Nlight Inc does not correlate significantly with that of Medtronic Plc.
Helen Of Troy Limited 655.40 1,907.41 123.75 2,498
A negative correlation coefficient of -0.393 implies that the revenue of Helen Of Troy Limited does not correlate significantly with that of Medtronic Plc.
Arconic Corporation 3,050.71 8,141.00 -254.00 13,000
A negative correlation coefficient of -0.179 implies that the revenue of Arconic Corporation does not correlate significantly with that of Medtronic Plc.
Haynes International inc 785.80 613.50 37.51 900
Haynes International inc 's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.654
Universal Stainless and Alloy Products Inc 447.32 325.47 26.65 622
The revenue of Universal Stainless and Alloy Products Inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.164
Solitario Resources Corp 56.37 0.32 -5.15 15
A negative correlation coefficient of -0.014 implies that the revenue of Solitario Resources Corp does not correlate significantly with that of Medtronic Plc.
Ingevity Corporation 1,630.12 1,350.70 -353.80 1,700
A negative correlation coefficient of -0.086 implies that the revenue of Ingevity Corporation does not correlate significantly with that of Medtronic Plc.
Stepan Company 1,271.07 2,221.40 56.19 2,389
The factor of 0.224 indicates a mild correlation between Stepan Company's revenue and those of Medtronic Plc.
Trinseo Plc 117.55 3,556.60 -704.80 3,100
Trinseo Plc's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.449
Vystar Corporation 1.19 0.15 -6.60 202
Dmc Global Inc 158.33 635.42 -152.42 314
The factor of 0.202 indicates a mild correlation between Dmc Global Inc 's revenue and those of Medtronic Plc.
Liquidmetal Technologies Inc 100.90 0.97 -1.77 18
A negative correlation coefficient of -0.239 implies that the revenue of Liquidmetal Technologies Inc does not correlate significantly with that of Medtronic Plc.
Mueller Industries Inc 8,860.32 3,919.28 635.12 4,509
Mueller Industries Inc's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.484
Materion Corporation 1,703.99 1,718.95 10.18 2,224
The revenue of Materion Corporation does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.136
Ryerson Holding Corporation 661.42 4,495.20 -5.20 2,400
The revenue of Ryerson Holding Corporation does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.109
Calumet Inc 1,222.97 4,176.90 -342.40 202
A negative correlation coefficient of -0.077 implies that the revenue of Calumet Inc does not correlate significantly with that of Medtronic Plc.
Couchbase Inc 1,039.64 184.98 -76.87 792
The revenue of Couchbase Inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.004
Ipg Photonics Corp 2,911.29 951.43 -201.87 6,180
A negative correlation coefficient of -0.014 implies that the revenue of Ipg Photonics Corp does not correlate significantly with that of Medtronic Plc.
Lightpath Technologies Inc 118.71 33.63 -10.17 316
Lightpath Technologies Inc 's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.466
Viavi Solutions Inc 2,126.05 1,046.20 5.10 3,600
Viavi Solutions Inc 's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.482
Mongodb Inc 17,071.41 1,781.64 -133.63 2,819
The revenue of Mongodb Inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.084
Elastic N v 8,646.00 1,482.42 -108.11 3,187
The revenue of Elastic N v does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.140
Wolfspeed Inc 220.07 759.50 -1,512.90 5,013
The factor of 0.235 indicates a mild correlation between Wolfspeed Inc 's revenue and those of Medtronic Plc.
Eltek Ltd 66.18 46.53 4.22 841
The revenue of Eltek Ltd does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.001
Interlink Electronics inc 59.09 10.54 -2.45 102
The revenue of Interlink Electronics inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.048
SUBTOTAL 992,824.28 703,139.30 57,745.49 359,872


  News about Medtronic Plc Contracts




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com